Table 2.
Treatment and doses | DNA Fragmentation % in spleen (Mean ± SE) | No. of cells with comets in testes | Class* | DNA damaged cells % (Mean ± SE) | |||
---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | ||||
(−ve) control | 9.5 ± 0.71a | 36 | 464 | 25 | 11 | 0 | 7.21 ± 1.07a |
Vinblastine 3 mg | 10.2 ± 0.49a,b | 39 | 461 | 23 | 16 | 0 | 7.83 ± 0.93b |
4.5 mg | 12.4 ± 0.47c | 51 | 449 | 28 | 17 | 6 | 10.24 ± 1.24c |
6 mg | 18.6 ± 0.67c,d | 83 | 417 | 31 | 28 | 24 | 16.61 ± 1.50c,d |
10 mg | 24.2 ± 0.88d | 107 | 393 | 35 | 31 | 41 | 21.43 ± 1.21d |
A total of 500 cells were analyzed for comets (five mice per group; 100 cells/mouse). *: Class 0 = no tail; 1 = tail length < diameter of nucleus; 2 = tail length between 1 × , and 2 × the diameter of nucleus; and 3 = tail length > 2 × the diameter of nucleus. Data are presented as Mean ± SE. Means with different superscripts (a,b,c,d) between groups in the same column are significantly different at P < 0.05